|

anti-PD-1 antibody and chemotherapy Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • Fudan University2

Indications

  • Breast Cancer2
  • Cancer2
  • HER2-negative Breast Cancer1
  • Triple Negative Breast Cancer1

Other2 trials

Reverse HER2-negative Immune Resistant Breast Cancer
Phase 2
Reverse Triple Negative Immune Resistant Breast Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.